Indian hospitals have seen a large impact due to the COVID-19 pandemic, especially among small and medium-sized healthcare providers, said a Nathealth study.
Aster DM Healthcare Limited, through its wholly owned subsidiary companies, has acquired 100 percent of Warseps Healthcare LLP.
Industry body FICCI, while welcoming the steps towards Atmanirbhar Bharat, stated that public spending on healthcare should be increased to at least 2.5% of GDP, which has been assured in the National Health Policy 2017.
The private healthcare sector is expected to witness short term operating losses to the tune of Rs 14,000 to Rs 24,000 crore for a quarter due to the outbreak of COVID-19 and the subsequent lockdown in India.
Credit rating agency ICRA Ratings has estimated the impact of COVID-19 on the hospital industry to be negative in the short-term.
Fortis Healthcare has earmarked a total of 262 beds to treat COVID-19 patients and set up isolation wards in all of its 28 hospitals across the country.
COVID-19 National Teleconsultation Centre (CoNTeC) has been launched at the All India Institute of Medical Sciences (AIIMS), New Delhi, recently.
KIMS Healthcare group has opened a new medical centre at Manacaud in Trivandrum, as part of its expansion activities in the capital city.
Tattvan, a telemedicine healthcare e-clinic, has launched ‘Second Medical Opinion’ service for multispecialty advanced care patients across India.
Hinduja Hospital recently hosted the 9th annual joint leadership meeting of RePORT India Consortium under the Department of Biotechnology (DBT) and the National Institute of Health, (NIH) USA at Mumbai.
Lorlatinib (Lorbrena) has been granted US FDA approval to treat patients with ALK-positive metastatic non-small cell lung cancer (NSCLC), Pfizer Inc announced.
More than 32,498 new positive COVID cases were reported on Wednesday taking the total confirmed cases in the country to 9,701,63. As per the data from the Union Health Ministry, there are as many as 3,31,486 active cases and 6,13,734 has been recovered until now. The death toll stands at 24,943.
The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network. Based at the Nobel laureates-driven Fred Hutchinson Cancer Research Center and funded by NIH, HVTN joined the COVID-19 response by initiating their first clinical trial.
